Literature DB >> 16775489

Characterization of ileal dendritic cell distribution in a rat model of acute and chronic inflammation.

Manuel A Silva1, Mónica Porras, Jennifer Jury, Patri Vergara, Mary H Perdue.   

Abstract

We examined ileal dendritic cell (DC) subpopulations in a rat model of indomethacin-induced enteritis to determine changes in phenotype and distribution associated with increased mucosal permeability during acute and chronic stages of inflammation. Sprague-Dawley rats were treated with indomethacin (7.5 mg/kg subcutaneously, 2 injections 48 h apart). Animals were killed at day 4 (acute stage) or at day 15 or 30 (chronic stages); control rats were injected with saline. DC distribution was evaluated by immunohistochemistry for CD103, CD11b, CD83, and CD163; inflammation was assessed by light microscopy; and permeability was determined by flux of horseradish peroxidase in Ussing chambers. In controls, both immature DC subpopulations, CD103+CD11b+CD163-CD83- and CD103+CD11b-CD163-CD83-, were observed in the lamina propria, and the CD11b- population also was present in Peyer's patches. In acute inflammation, permeability was increased (P<0.01), and inflamed areas with or without ulcers were observed. CD103+ and CD11b+ (CD83-) DCs were absent from inflamed areas, reduced in noninflamed tissues, but present in Peyer's patches. In the chronic stage at day 15, CD103+ and CD11b+ cells were located in inflamed and noninflamed areas and in Peyer's patches. In addition, CD83+ DCs were detected in inflamed areas. At day 30, when we observed a complete microscopic resolution of inflammation, numbers of CD103+ and CD11b+ DCs were increased, and there were CD83+ DCs beneath the epithelial cell layer. We conclude that antigen uptake in acute inflammation may activate resident immature DCs, inducing their migration to lymphoid tissue where they mature and then return to the intestine to play a role in the local inflammatory response.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16775489     DOI: 10.1097/00054725-200606000-00004

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  6 in total

1.  Total parenteral-nutrition-mediated dendritic-cell activation and infiltration into the small intestine in a rat model.

Authors:  Satoshi Hagiwara; Hideo Iwasaka; Junya Kusaka; Nobuhiko Asai; Tomohisa Uchida; Takayuki Noguchi
Journal:  J Anesth       Date:  2010-11-06       Impact factor: 2.078

2.  Multispecies probiotic protects gut barrier function in experimental models.

Authors:  Mylene Nébot-Vivinus; Cherryl Harkat; Hanene Bzioueche; Christel Cartier; Raffaella Plichon-Dainese; Lara Moussa; Helene Eutamene; Dorsa Pishvaie; Sophie Holowacz; Christian Seyrig; Thierry Piche; Vassilia Theodorou
Journal:  World J Gastroenterol       Date:  2014-06-14       Impact factor: 5.742

3.  Targeted epithelial tight junction dysfunction causes immune activation and contributes to development of experimental colitis.

Authors:  Liping Su; Le Shen; Daniel R Clayburgh; Sam C Nalle; Erika A Sullivan; Jon B Meddings; Clara Abraham; Jerrold R Turner
Journal:  Gastroenterology       Date:  2008-11-06       Impact factor: 22.682

4.  Dendritic cells and toll-like receptors 2 and 4 in the ileum of Crohn's disease patients.

Authors:  Manuel A Silva; Rodrigo Quera; Jorge Valenzuela; Sa'ad Y Salim; Johan D Söderholm; Mary H Perdue
Journal:  Dig Dis Sci       Date:  2007-12-13       Impact factor: 3.199

5.  Dendritic cell activation in response to ischemia-reperfusion injury of the small intestine.

Authors:  Satoshi Hagiwara; Hideo Iwasaka; Akira Hasegawa; Nobuhiko Asai; Tomohisa Uchida; Takayuki Noguchi
Journal:  Surg Today       Date:  2010-01-28       Impact factor: 2.549

6.  Retinoic acid facilitates inactivated transmissible gastroenteritis virus induction of CD8(+) T-cell migration to the porcine gut.

Authors:  Xiaojuan Chen; Chongzhi Tu; Tao Qin; Liqi Zhu; Yinyan Yin; Qian Yang
Journal:  Sci Rep       Date:  2016-04-15       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.